July 18th 2025
States participating in the Cell and Gene Therapy (CGT) Access Model will be testing outcomes-based payments for sickle cell disease treatments.
Assessing Surgical Complications in Management of Hidradenitis Suppurativa
October 10th 2022Approximately 1 in 10 patients with hidradenitis suppurativa (HS) experienced complications related to surgery for HS management, in which extensive resection, using skin flaps or skin grafts as a closure method, was associated with a higher incidence of complications.
Read More
AMCP Nexus 2022 to Address Evolving Value-Based Frameworks, Shared Decision-Making
October 10th 2022The annual fall meeting of AMCP Nexus 2022 will feature a keynote from one of the top physician-executives in health care, the specialty pharmaceutical pipeline, and insights for managed care stakeholders in selecting and integrating cost-effective, value-based care frameworks.
Read More
Dr Melissa O'Connor on Development of Decision Support Tool For Discharge in Home Health
October 8th 2022Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in Community and Home Health Nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group, addressed gaps in research for home health care and progress toward the development of a discharge decision support tool for clinicians.
Watch
New eGFR Formula May Inappropriately Label Black Potential Kidney Donors as Having CKD
October 7th 2022This study found that the recent change to remove race from the calculation of estimated glomerular filtration rate (eGFR) may incorrectly label potential donors who are Black as having chronic kidney disease (CKD).
Read More
Advocate Addresses Unmet Needs in the Management of Hidradenitis Suppurativa
October 7th 2022Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected by hidradenitis suppurativa (HS), discussed several pressing issues that warrant consideration to improve the care management of HS.
Watch
Patients With RA Face Higher Risk of COVID-19, Hospitalization Even When Vaccinated
October 7th 2022Based on their findings, the researchers are emphasizing the importance of patients with rheumatoid arthritis (RA) receiving a booster vaccination, as well as other mitigation strategies, such as social distancing and wearing face masks.
Read More
Dr Jason Ezra Hawkes Addresses Immunotherapy Innovation, Uptake Issues in Atopic Dermatitis
October 6th 2022Jason Ezra Hawkes, MD, MS, FAAD, board-certified dermatologist and associate professor of dermatology at the University of California Davis in Sacramento, discussed recent advancements in immunotherapy for atopic dermatitis and what unmet needs persist to address uptake issues and patient-specific care needs.
Watch
The authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.
Read More
Prior Authorization Can Work in MA but Not Without Changes, Researchers Say
October 6th 2022In a recent opinion published in JAMA, health policy researchers reviewed the advantages and disadvantages of prior authorization in Medicare Advantage (MA) to identify key areas that need improvement.
Read More
Community-Based Cycling Program Shows Positive Impact on Symptom Management in Parkinson Disease
October 3rd 2022Location, cost, and transportation were cited as important factors regarding adherence and satisfaction with community-based exercise programs among patients with Parkinson disease.
Read More
Svante Pääbo was awarded the Nobel Prize in Physiology or Medicine for his discoveries in human evolution; the amyotrophic lateral sclerosis (ALA drug AMX0035 was priced at $158,000 per year or about $12,500 per 28-day prescription; more than 16,000 Americans died of combination cancer and COVID-19 in the first 10 months of the pandemic.
Read More
T&E Regimen, Consistent Adherence Important to Management of nAMD
October 2nd 2022Posters presented at the American Academy of Ophthalmology 2022 annual meeting show that the treat-and-extend (T&E) regimen was effective in managing neovascular age-related macular degeneration (nAMD), which makes adherence to treatment vital for long-term outcomes.
Read More
Which DME Drug to Try First? Patients on Bevacizumab Can Successfully Transition to Aflibercept
October 2nd 2022The presentation focused on the Protocol AC trial, which considered whether step therapy had an impact on visual outcomes for patients starting on bevacizumab and switching to aflibercept later.
Read More
Panel Reviews Health Inequities and Opportunities for Innovation Through Population Health Delivery
September 30th 2022A panel discussion at the 70th Annual Roy A. Bowers Pharmaceutical Conference addressed recent care delivery initiatives in New Jersey that aim to address health inequities and other population health concerns.
Read More
Advanced Imaging System Investigated for Faster Diagnosis of Skin Cancers
September 30th 2022This new study explored the diagnostic utility and accuracy of 2-photon fluorescence microscopy (TPFM) among nonmelanoma skin cancers, which included basal cell carcinoma and squamous cell carcinoma.
Read More